Knopp Biosciences reports positive data from pilot study of dexpramipexole to treat HES

US-based drug discovery and development company Knopp Biosciences has reported positive data from its pilot study of dexpramipexole to treat patients with hypereosinophilic syndromes (HES).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Study